Skip to content
20-F

Annual Report (Foreign)

Pharming Group N.V. PHAR

0001828316-26-000015

← back to feed
Filed
Apr 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 688.77M sh
Shares Diluted FY 2025 · Dec 31, 2024 671.35M sh
Shares Diluted FY 2025 · Dec 31, 2023 657.02M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $54.71M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$1.8M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$17.3M
Cash And Equivalents FY 2025 · Dec 31, 2025 $145.31M
Cash And Equivalents FY 2025 · Dec 31, 2024 $54.94M
Cash And Equivalents FY 2025 · Dec 31, 2023 $61.74M
Cash And Equivalents FY 2025 · Dec 31, 2022 $207.34M
Stockholders Equity FY 2025 · Dec 31, 2025 $277.1M
Stockholders Equity FY 2025 · Dec 31, 2024 $221.06M
Stockholders Equity FY 2025 · Dec 31, 2023 $218.78M
Stockholders Equity FY 2025 · Dec 31, 2022 $204.64M
Current Liabilities FY 2025 · Dec 31, 2025 $115.79M
Current Liabilities FY 2025 · Dec 31, 2024 $73.8M
Current Assets FY 2025 · Dec 31, 2025 $299.47M
Current Assets FY 2025 · Dec 31, 2024 $278.44M
Total Assets FY 2025 · Dec 31, 2025 $499.96M
Total Assets FY 2025 · Dec 31, 2024 $399.99M
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 −$0.02
Eps Diluted FY 2025 · Dec 31, 2023 −$0.02
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2024 −$0.02
Eps Basic FY 2025 · Dec 31, 2023 −$0.02
Rd Expense FY 2025 · Dec 31, 2025 $100.37M
Rd Expense FY 2025 · Dec 31, 2024 $83.15M
Rd Expense FY 2025 · Dec 31, 2023 $68.91M
Net Income FY 2025 · Dec 31, 2025 $2.54M
Net Income FY 2025 · Dec 31, 2024 −$11.84M
Net Income FY 2025 · Dec 31, 2023 −$10.55M
Operating Income FY 2025 · Dec 31, 2025 $25.84M
Operating Income FY 2025 · Dec 31, 2024 −$8.62M
Operating Income FY 2025 · Dec 31, 2023 −$5.39M
Gross Profit FY 2025 · Dec 31, 2025 $330.63M
Gross Profit FY 2025 · Dec 31, 2024 $261.8M
Gross Profit FY 2025 · Dec 31, 2023 $220.1M
Cost Of Revenue FY 2025 · Dec 31, 2025 $45.5M
Cost Of Revenue FY 2025 · Dec 31, 2024 $35.4M
Cost Of Revenue FY 2025 · Dec 31, 2023 $25.21M